Helping adults with Type 1 diabetes use advanced insulin devices more effectively
ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices
This study is all about helping adults with Type 1 diabetes use advanced tools like continuous glucose monitors and insulin delivery systems more effectively, by finding out what challenges they face and offering personalized support to make managing their diabetes easier and improve their quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10889439 on NIH RePORTER |
What this research studies
This research focuses on improving the adoption and sustained use of advanced diabetes management technologies, such as continuous glucose monitors (CGMs) and closed-loop insulin delivery systems, among adults with Type 1 diabetes. It aims to identify and address the barriers that prevent effective use of these devices, providing tailored education and support to empower patients. By utilizing behavioral interventions, the project seeks to enhance patients' self-management skills and overall quality of life. The research will involve a series of studies designed to develop effective strategies for overcoming obstacles to device adoption.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 18 to 50 with Type 1 diabetes who are either currently using or considering the use of continuous glucose monitors.
Not a fit: Patients who do not have Type 1 diabetes or those outside the age range of 18 to 50 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and better health outcomes for adults with Type 1 diabetes.
How similar studies have performed: Previous research has shown that behavioral interventions can effectively improve the adoption and use of diabetes management technologies, indicating a promising approach in this area.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Tanenbaum, Molly Leah — Stanford University
- Study coordinator: Tanenbaum, Molly Leah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.